Lesson plan

CEPP

CEPP is a chemotherapy regimen that is intended for treatment of aggressive non-Hodgkin lymphomas. It consists of cyclophosphamide, etoposide, procarbazine, and prednisone. Unlike CHOP, this chemotherapy regimen does not contain doxorubicin or any other anthracycline. Thus, it can be used in patients with severe cardiovascular diseases and contraindications for doxorubicin-containing regimens. This regimen also does not contain vincristine and can be used in patients with neuropathy. There are several modifications of CEPP. In combination with bleomycin, this regimen is called CEPP (B). With the further addition of the anti-CD20 monoclonal antibody rituximab, it is called R-CEPP(B). R-CEPP(B) regimen consists of: * Rituximab - a monoclonal antibody that is able to kill CD20-positive B cells, either normal or malignant * Cyclophosphamide - an alkylating antineoplastic agent * Etoposide- a topoisomerase inhibitor from the epipodophyllotoxin group * Procarbazine - an alkylating antineoplastic agent * Prednisone or prednisolone - a glucocorticoid hormone that has the ability to cause apoptosis and lysis of lymphocytes, either normal or malignant * Bleomycin - an antitumor antibiotic

Back to article

Article summary

CEPP is a chemotherapy regimen that is intended for treatment of aggressive non-Hodgkin lymphomas. It consists of cyclophosphamide, etoposide, procarbazine, and prednisone. Unlike CHOP, this chemotherapy regimen does not contain doxorubicin or any other anthracycline. Thus, it can be used in patients with severe cardiovascular diseases and contraindications for doxorubicin-containing regimens. This regimen also does not contain vincristine and can be used in patients with neuropathy. There are several modifications of CEPP. In combination with bleomycin, this regimen is called CEPP (B). With the further addition of the anti-CD20 monoclonal antibody rituximab, it is called R-CEPP(B). R-CEPP(B) regimen consists of: * Rituximab - a monoclonal antibody that is able to kill CD20-positive B cells, either normal or malignant * Cyclophosphamide - an alkylating antineoplastic agent * Etoposide- a topoisomerase inhibitor from the epipodophyllotoxin group * Procarbazine - an alkylating antineoplastic agent * Prednisone or prednisolone - a glucocorticoid hormone that has the ability to cause apoptosis and lysis of lymphocytes, either normal or malignant * Bleomycin - an antitumor antibiotic

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.